RO7617991

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7617991, covering 2024-09-03 to 2024-09-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors [Phase 1]